FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Effwa Infra and Research IPO and Nephro Care India IPO.
Effwa Infra and Research IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Nephro Care India IPO is a SME Book Built Issue proposed to list at NSE SME.
Effwa Infra and Research IPO | Nephro Care India IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Shreni Shares Limited | Corporate Capitalventures Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | Rikhav Securities Limited | Ss Corporate Securities Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Effwa Infra and Research IPO is up to ₹51.27 Cr whereas the issue size of the Nephro Care India IPO is up to ₹41.26 Cr. The final issue price of Effwa Infra and Research IPO is ₹82.00 per share and of Nephro Care India IPO is ₹90.00 per share.
Effwa Infra and Research IPO | Nephro Care India IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹78.00 per share | ₹85.00 per share |
Issue Price (Upper) | ₹82.00 per share | ₹90.00 per share |
Issue Price (Final) | ₹82.00 per share | ₹90.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 1600 shares |
Fresh Issue Size | 53,16,800 shares | 45,84,000 shares |
Fresh Issue Size (Amount) | up to ₹43.60 Cr | up to ₹41.26 Cr |
OFS Issue Size | 9,36,000 shares | |
OFS Issue Size (Amount) | up to ₹7.68 Cr | |
Issue Size Total | 62,52,800 shares | 45,84,000 shares |
Issue Size Total (Amount) | up to ₹51.27 Cr | up to ₹41.26 Cr |
Effwa Infra and Research IPO opens on Jul 05, 2024, while Nephro Care India IPO opens on Jun 28, 2024. The closing date of Effwa Infra and Research IPO and Nephro Care India IPO is Jul 09, 2024, and Jul 02, 2024, respectively.
Effwa Infra and Research IPO | Nephro Care India IPO | |
---|---|---|
Anchor Bid Date | Jul 04, 2024 | Jun 27, 2024 |
Issue Open | Jul 05, 2024 | Jun 28, 2024 |
Issue Close | Jul 09, 2024 | Jul 02, 2024 |
Basis Of Allotment (Tentative) | Jul 10, 2024 | Jul 03, 2024 |
Initiation of Refunds (Tentative) | Jul 11, 2024 | Jul 04, 2024 |
Credit of Share (Tentative) | Jul 11, 2024 | Jul 04, 2024 |
Listing date (Tentative) | Jul 12, 2024 | Jul 05, 2024 |
Anchor Lockin End date 1 | Aug 09, 2024 | Aug 02, 2024 |
Anchor Lockin End date 2 | Oct 08, 2024 | Oct 01, 2024 |
Effwa Infra and Research IPO P/E ratio is 10.59, as compared to Nephro Care India IPO P/E ratio of 55.15.
Effwa Infra and Research IPO | Nephro Care India IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Effwa Infra & Research Limited Financial Information (Restated)Effwa Infra & Research Limited's revenue increased by 26.08% and profit after tax (PAT) rose by 169% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Nephro Care India Limited Financial Information (Restated)Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.99% | 85.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 72.99% | 61.39% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 10.59 | 55.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹189.81 Cr. | ₹148.38 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 45.46%% | 41.57%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 40.99%% | 36.56%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.38 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹7.74 | ₹1.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 37.15%% | 24.42%% |
In the Effwa Infra and Research IPO retail investors (RII) are offered 20,91,200 shares while in Nephro Care India IPO retail investors are offered 20,91,200 shares. Qualified institutional buyers (QIB) are offered 11,68,000 shares in Effwa Infra and Research IPO and 8,25,600 shares in Nephro Care India IPO.
Effwa Infra and Research IPO | Nephro Care India IPO | |
---|---|---|
Anchor Investor Reserveration | 17,48,800 shares | 12,38,400 shares |
Market Maker Reserveration | 3,24,800 shares | 2,30,400 shares |
QIB | 11,68,000 shares | 8,25,600 shares |
NII | 9,20,000 shares | 6,19,200 shares |
RII | 20,91,200 shares | 14,44,800 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 41,79,200 shares | 31,15,200 shares |
Effwa Infra and Research IPO subscribed 313.65x in total, whereas Nephro Care India IPO subscribed 715.78x.
Effwa Infra and Research IPO | Nephro Care India IPO | |
---|---|---|
QIB (times) | 166.56x | 245.14x |
NII (times) | 477.27x | 1,787.19x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 323.81x | 634.12x |
Employee (times) | ||
Other (times) | ||
Total (times) | 313.65x | 715.78x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|